United States

Sunovion to acquire Elevation Pharma

Thursday, August 30, 2012 01:42 PM

Sunovion Pharmaceuticals, a Marlborough, Mass.-based pharmaceutical company focused on the central nervous system and respiratory disease, has agreed to acquire San Diego-based Elevation Pharmaceuticals, which specializes in the development of new aerosol therapies for patients with respiratory diseases.

More... »

Leukemia & Lymphoma Society awards $12M in grants for blood cancer

Thursday, August 30, 2012 11:54 AM

The Leukemia & Lymphoma Society (LLS) of White Plains, N.Y., has awarded 20 grants representing a total investment of $12 million to tackle four areas of high unmet medical need in the blood cancers.

More... »

Hospira to expand operations, create 200 jobs

Wednesday, August 29, 2012 11:20 AM

Hospira, a provider of injectable medicines and infusion technologies, is modernizing and expanding the capabilities of its operations in Nash County of N.C.

More... »

Novira secures $23M Series A financing for Hep B, HIV

Wednesday, August 29, 2012 11:12 AM

Novira Therapeutics, an antiviral drug discovery company, has secured $23 million in Series A financing to support the development of its capsid-targeting antivirals for the treatment of chronic hepatitis B (HBV) and HIV infections.

More... »

FDA approves Gilead's Stribild, four-in-one HIV drug

Wednesday, August 29, 2012 10:19 AM

The FDA has approved Stribild, a complete once-daily single tablet regimen, for the treatment of HIV-1 infection in treatment-naïve adults, according to Gilead Sciences, the Foster City, Calif.-based biopharmaceutical company that developed the drug.

More... »

Oxygen Biotherapeutics relocating R&D function to North Carolina

Wednesday, August 29, 2012 10:04 AM

Oxygen Biotherapeutics, a Morrisville, N.C.-based developer of medical and cosmetic products that efficiently deliver oxygen to tissues in the body, is searching for laboratory space in the Research Triangle Park region of North Carolina.

More... »

Alnylam and Monsanto form strategic alliance

Tuesday, August 28, 2012 02:51 PM

St. Louis-based Monsanto and Alnylam Pharmaceuticals of Cambridge, Mass., have formed a strategic alliance to advance biological technologies in the field of agriculture. The new alliance brings Alnylam's broad RNAi-based intellectual property (IP) and proprietary technologies to Monsanto's new BioDirect technology, which aims to deliver innovative biological solutions for farmers.

More... »

ERT introduces enhanced platform to streamline clinical trial data collection

Tuesday, August 28, 2012 12:31 PM

Philadelphia-based ERT, a global provider of health outcomes services, has launched an enhanced clinical research workflow technology designed to streamline data collection, analysis and processing in clinical trials. The new offering, which comprises the EXPERT3 workflow platform and MyStudyPortal3 reporting engine, can simultaneously process health outcomes data across cardiac safety, Clinical Outcome Assessment (COA)/ePRO and respiratory studies. The platform offers users a simple way to process multiple types of data accurately, leading to fewer errors in studies.

More... »

Pristine Solutions acquires Eaton Scientific Systems

Monday, August 27, 2012 12:08 PM

Pristine Solutions has completed the acquisition of Eaton Scientific Systems, a biomedical product development company focused on women's health solutions.

More... »

Proteonomix licenses exclusive worldwide rights to novel anti-tumor technology

Thursday, August 23, 2012 10:19 AM

Proteonomix, a Hawthorne, N.J.-based biotechnology company focused therapeutics based upon the use of human cells and their derivatives, has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.

More... »